Emergent BioSolutions (EBS) Fails to deliver data

Key failure to deliver metrics for Emergent BioSolutions :

• Last SEC data release: 2026-02-13
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: HK$0.45 M
• Last 12 months FTD volume: HK$3.69 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Emergent BioSolutions (EBS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013

Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	HK$56.63 M	HK$0.12 B	🇺🇸 USA
Merck MRK	HK$0.11 B	HK$0.20 B	🇺🇸 USA
GSK plc GSK	HK$26.89 M	HK$0.35 B	🇬🇧 UK
Soligenix SNGX	HK$0.53 M	HK$14 M	🇺🇸 USA
SIGA Technologies SIGA	HK$0.09 M	HK$0.88 M	🇺🇸 USA
Celldex Therapeutics CLDX	HK$1.47 M	HK$11.36 M	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	HK$59.58 M	HK$89.35 M	🇮🇱 Israel